Grant ID RP130570
Awarded On December 05, 2012
Title Single-Cell Biomarkers of Clinical-Grade T Cells and NK Cells to Optimize Tumor Immunotherapy
Program Academic Research
Award Mechanism Individual Investigator
Institution/Organization University of Houston
Principal Investigator/Program Director Navin Varadarajan
Cancer Sites All Sites, Leukemia
Contracted Amount $1,279,584
Lay Summary

Adoptive cell therapy is a cutting-edge treatment option for diverse kinds of cancers. In this grant application we will employ a single-cell methodology to characterize the heterogeneity of cells used for adoptive cell therapy to better define the potency of cell based therapies. The successful implementation of the aims of the grant will facilitate more rapid translation of ACT based therapies and will ensure that Texans are the first to benefit from the next generation of clinical trials based on ACT.